Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home
  
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Measuring the Abundance of Extremely Rare Mutations
Researchers from Rutgers University demonstrate the use of multiplex real-time PCR assays to measure the abundance of extremely rare mutations associated with cancer.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
New Tool Could Change How Infectious Diseases Are Diagnosed
Scientists at the University of Utah School of Medicine, ARUP Laboratories, and IDbyDNA, Inc., have developed ultra-fast, meta-genomics analysis software called Taxonomer that dramatically improves the accuracy and speed of pathogen detection.
Finding Zika One Paper Disc At A Time
A novel, inexpensive method for detecting the Zika virus could help slow spread of outbreak, and potentially other future pandemic diseases.
Rapid Diagnosis of Bacterial Infections
Mass. General-developed compact system could shorten diagnostic time from days to hours, bring testing to point of care.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Gene Analysis System Could Accelerate Pace of Research on the Space Station
The WetLab-2 system will enable spaceflight genomic studies involving a wide variety of biospecimen types in the unique microgravity environment of space.

Epigenetics Market Trends 2011
Bookmark and Share

Published: January 2011
Pages: 76

This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers.

This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.

This report also examines qualitative and in quantitative terms the research market landscape of epigenetics as it exists currently based on Select Biosciences bottom-up market research on this topic. Presented is market segmentation of epigenetics based on end-user research, based on technology utilization, and based on specific disease areas being studied. The primary market data are derived from a worldwide respondent pool that is highly-representative of the life science research community and therefore provides an excellent proxy for the understanding of the research trends operative in this space.

In addition to characterization of the epigenetics research marketplace, this report also presents an analysis of epigenetic biomarkers and their deployment as potential diagnostics. Also presented herein are the efforts vis-à-vis deployment of epigenetics as therapeutics—in this vein the clinical pipeline as it exists currently is presented.

This data-driven characterization of the epigenetics research landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Characterization of Epigenetics Modifications
  • DNA Methylation, the Various Histone Modifications and their Qualitative Effects In Vivo
  • Epigenetic Silencing of Genes and Pathways: Mechanism and Effects
  • Tumor Suppressor Genes Silenced In Vivo
  • Specific Genes Modulated via Epigenetics In Various Diseases
  • Market Segmentation of Epigenetics by Disease Class
  • Epigenetics Market Segmentation
  • Epigenetics Market Segmentation by End-User Research Penetrance
  • Epigenetics Market Quantitative Segmentation by type of Modification Studied
  • Epigenetics Market Segmentation by Type of HDAC Studied
  • Penetrance of Product Vendors into Various Segments of the Epigenetics Marketplace: Quantitative Analysis
  • Emerging Trends and Themes in Epigenetics
  • Current Studies of microRNAs, non-coding RNAs, and Tumor Suppressor Genes in the Epigenetics Marketplace
  • Epigenetics-based Diagnostics: Epigenetics-based Biomarkers and their Current Status
  • Epigenetics-based Therapeutics: The current Clinical Pipeline of Approved and In-Development Therapeutics


Related Content

Agendas online
The conference agendas for Advances in qPCR, RNAi & miRNA World Congress, Epigenetics World Congress and Next-Gen Sequencing Congress to be held 26-27 April, 2011 in Boston, MA, USA have now been released.
Friday, January 07, 2011
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!